Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Depersonalization
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Causes == Depersonalization can arise from a variety of factors, of both a psychological and physiological nature. Common immediate precipitants include instances of [[Stress (biology)|severe stress]], [[Major depressive episode|depressive episodes]], [[panic attack]]s, and the consumption of psychoactive substances such as [[marijuana]] and [[hallucinogen]]s. Additionally, there exists a correlation between frequent depersonalization and [[Childhood trauma|childhood interpersonal trauma]], particularly cases involving [[Psychological abuse|emotional maltreatment.]]<ref name="Simeon-2004" /> A [[case-control study]] conducted at a specialized depersonalization clinic included 164 individuals with chronic depersonalization symptoms, of which 40 linked their symptoms to illicit drug use. [[Phenomenology (philosophy)|Phenomenological]] similarity between drug-induced and non-drug groups was observed, and comparison with [[Matching (statistics)|matched controls]] further supported the lack of distinction. The severity of clinical depersonalization symptoms remains consistent regardless of whether they are triggered by illicit drugs or psychological factors.<ref>{{Cite journal |last1=Medford |first1=Nicholas |last2=Baker |first2=Dawn |last3=Hunter |first3=Elaine |last4=Sierra |first4=Mauricio |last5=Lawrence |first5=Emma |last6=Phillips |first6=Mary L. |last7=David |first7=Anthony S. |date=December 2003 |title=Chronic depersonalization following illicit drug use: a controlled analysis of 40 cases |url=https://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2003.00548.x |journal=Addiction |language=en |volume=98 |issue=12 |pages=1731–1736 |doi=10.1111/j.1360-0443.2003.00548.x |pmid=14651505 |issn=0965-2140 |access-date=2024-03-30 |archive-date=2023-04-30 |archive-url=https://web.archive.org/web/20230430211010/https://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2003.00548.x |url-status=live |url-access=subscription }}</ref> === Pharmacological === Depersonalization has been described by some as a desirable state, particularly by those that have experienced it under the influence of mood-altering [[recreational drugs]]. It is an effect of [[dissociatives]] and [[psychedelics]], as well as a possible side effect of [[caffeine]], [[alcohol (drug)|alcohol]], [[amphetamine]], [[Cannabis (drug)|cannabis]], and [[antidepressants]].<ref>{{cite journal |last1=Stein |first1=M. B. |last2=Uhde |first2=TW |title=Depersonalization Disorder: Effects of Caffeine and Response to Pharmacotherapy |journal=[[Biological Psychiatry]] |volume=26 |issue=3 |pages=315–20 |date=July 1989 |doi=10.1016/0006-3223(89)90044-9 |pmid=2742946 |s2cid=34396397 |url=https://zenodo.org/record/1253828 |access-date=2019-07-12 |archive-date=2024-01-26 |archive-url=https://web.archive.org/web/20240126213205/https://zenodo.org/records/1253828 |url-status=live }}</ref><ref>{{cite journal |last=Raimo |first=E. B. |author2=R. A. Roemer |author3=M. Moster |author4=Y. Shan |title=Alcohol-Induced Depersonalization |journal=[[Biological Psychiatry]] |date=June 1999 |doi=10.1016/S0006-3223(98)00257-1 |volume=45 |pages=1523–6 |pmid=10356638 |issue=11|s2cid=34049706}}</ref><ref name="pmid14746427">{{cite journal |last=Cohen |first=P. R. |title=Medication-associated depersonalization symptoms: report of transient depersonalization symptoms induced by minocycline |journal=[[Southern Medical Journal]] |volume=97 |issue=1 |pages=70–73 |year=2004 |pmid=14746427 |doi=10.1097/01.SMJ.0000083857.98870.98 |s2cid=27125601}}</ref><ref>{{cite web |url=http://www.medscape.com/viewarticle/468728_3 |title=Medication-Associated Depersonalization Symptoms |publisher=medscape.com |access-date=2009-03-30 |archive-date=2015-02-14 |archive-url=https://web.archive.org/web/20150214055436/http://www.medscape.com/viewarticle/468728_3 |url-status=live }}</ref><ref>{{cite journal |title=Depersonalization Again Finds Psychiatric Spotlight |journal=[[Psychiatric News]] |date=2003-08-15 |volume=38 |issue=16 |pages=18–30 |doi=10.1176/pn.38.16.0018 |last1=Arehart-Treichel |first1=Joan}}</ref> It is a classic [[Drug withdrawal|withdrawal]] symptom from many drugs.<ref name="pmid8104417">{{cite journal |last=Marriott |first=S. |author2=P. Tyrer |title=Benzodiazepine dependence: avoidance and withdrawal |journal=Drug Safety |volume=9 |issue=2 |pages=93–103 |year=1993 |pmid=8104417 |doi=10.2165/00002018-199309020-00003|s2cid=8550990 }}</ref><ref name="pmid15889607">{{cite journal |last=Shufman |first=E. |author2=A. Lerner |author3=E. Witztum |trans-title=Depersonalization after withdrawal from cannabis usage |language=he |journal=Harefuah |volume=144 |issue=4 |pages=249–51 and 303 |year=2005 |pmid=15889607|title=Depersonalization after withdrawal from cannabis usage}}</ref><ref name="pmid7085580">{{cite journal |last=Djenderedjian |first=A. |author2=R. Tashjian |title=Agoraphobia following amphetamine withdrawal |journal=The Journal of Clinical Psychiatry |volume=43 |issue=6 |pages=248–49 |year=1982 |pmid=7085580}}</ref><ref name="pmid9696914">{{cite journal |last=Mourad |first=I. |author2=M. Lejoyeux |author3=J. Adès |title=Evaluation prospective du sevrage des antidépresseurs |trans-title=Prospective evaluation of antidepressant discontinuation |language=fr |journal=[[L'Encéphale]] |volume=24 |issue=3 |pages=215–22 |year=1998 |pmid=9696914}}</ref> [[Benzodiazepine dependence]], which can occur with long-term use of benzodiazepines, can induce chronic depersonalization symptomatology and perceptual disturbances in some people, even in those who are taking a stable daily dosage, and it can also become a protracted feature of the [[benzodiazepine withdrawal syndrome]].<ref>{{cite journal |doi=10.1016/0740-5472(91)90023-4 |pmid=1675688 |title=Protracted withdrawal syndromes from benzodiazepines |journal=Journal of Substance Abuse Treatment |volume=8 |issue=1–2 |pages=19–28 |year=1991 |last1=Ashton |first1=Heather }}</ref><ref>{{cite journal |author=Terao T |author2=Yoshimura R |author3=Terao M |author4=Abe K |title=Depersonalization following nitrazepam withdrawal |journal=[[Biological Psychiatry]] |volume=31 |issue=2 |pages=212–3 |date=1992-01-15 |pmid=1737083 |doi=10.1016/0006-3223(92)90209-I |s2cid=26522217}}</ref> Lieutenant Colonel [[Dave Grossman (author)|Dave Grossman]], in his book ''[[On Killing]]'', suggests that military training artificially creates depersonalization in soldiers, suppressing [[empathy]] and making it easier for them to kill other human beings.<ref>{{Cite book |last=Grossman |first=Dave |title=On Killing: The Psychological Cost of Learning to Kill in War and Society |publisher=Back Bay Books |year=1996 |isbn=978-0-316-33000-8 |url=https://books.google.com/books?id=BewqAwAAQBAJ&q=depersonalization}}</ref> [[Graham Reed (psychologist)|Graham Reed]] (1974) claimed that depersonalization occurs in relation to the experience of falling in love.<ref>{{cite book |last1=Reed |first1=Graham |year=1972 |title=The Psychology of Anomalous Experience |url=https://archive.org/details/amf00grah |url-access=registration |publisher=Hutchinson |page=[https://archive.org/details/amf00grah/page/127 127] |isbn=9780091132408}}</ref> === Situational === Experiences of depersonalization/derealization occur on a continuum, ranging from momentary episodes in healthy individuals under conditions of [[Stress (biology)|stress]], [[fatigue]], or [[Drug|drug use]], to severe and chronic disorders that can persist for decades.<ref name=":0" /> Several studies found that up to 66% of individuals in [[Near-death experience|life-threatening accidents]] report at least transient depersonalization during or immediately after the accidents.<ref name="Sadock2017-Epid-DP-DR" /> Several studies, but not all, found age to be a significant factor: [[adolescents]] and [[young adults]] in the normal population reported the highest rate. In a study, 46% of college students reported at least one significant episode in the previous year. In another study, 20% of patients with minor head injury experience significant depersonalization and derealization. In [[general infantry]] and [[special forces]] soldiers, measures of depersonalization and derealization increased significantly after [[Military education and training|training]] that includes experiences of uncontrollable stress, semi-starvation, [[sleep deprivation]], as well as lack of control over [[hygiene]], movement, [[communications]], and [[social interaction]]s.<ref name="Sadock2017-Epid-DP-DR" /> === Biological === Studies have linked dysregulation of the [[immune system]] with depersonalisation.<ref>{{Cite journal |last=Zheng |first=Sisi |last2=Feng |first2=Sitong |last3=Song |first3=Nan |last4=Chen |first4=Guangyao |last5=Jia |first5=Yuan |last6=Zhang |first6=Guofu |last7=Liu |first7=Min |last8=Li |first8=Xue |last9=Ning |first9=Yanzhe |last10=Wang |first10=Dan |last11=Jia |first11=Hongxiao |date=2024-05-27 |title=The role of the immune system in depersonalisation disorder |url=https://www.tandfonline.com/doi/full/10.1080/15622975.2024.2346096 |journal=The World Journal of Biological Psychiatry |language=en |volume=25 |issue=5 |pages=291–303 |doi=10.1080/15622975.2024.2346096 |issn=1562-2975|url-access=subscription }}</ref> Researchers compared protein expression in serum samples of individuals with [[Depersonalization-derealization disorder|depersonalisation/derealization disorder]] (DPDR, DDD) and healthy controls, and found that many key proteins involved in maintaining [[homeostasis]] were present at altered levels. Decreased levels of [[C-reactive protein|C-reactive protein (CRP)]], [[Complement component 1q|complement C1q subcomponent subunit B]], and apolipoprotein A-IV, and increased levels of alpha-1-antichymotrypsin (SERPINA3) were observed in patients with DPDR. Furthermore, expressions of CRP and SERPINA3 were found to be linked with the ability to inhibit cognitive interference of DPDR.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)